These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10103336)
1. Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature. Mehta P; Kedar A; Graham-Pole J; Skoda-Smith S; Wingard JR Pediatrics; 1999 Apr; 103(4):e44. PubMed ID: 10103336 [TBL] [Abstract][Full Text] [Related]
2. Thalidomide for the treatment of chronic graft-versus-host disease. Vogelsang GB; Farmer ER; Hess AD; Altamonte V; Beschorner WE; Jabs DA; Corio RL; Levin LS; Colvin OM; Wingard JR N Engl J Med; 1992 Apr; 326(16):1055-8. PubMed ID: 1549151 [TBL] [Abstract][Full Text] [Related]
3. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children. Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061 [TBL] [Abstract][Full Text] [Related]
4. Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation. Cole CH; Rogers PC; Pritchard S; Phillips G; Chan KW Bone Marrow Transplant; 1994 Dec; 14(6):937-42. PubMed ID: 7711671 [TBL] [Abstract][Full Text] [Related]
5. Response to thalidomide therapy in refractory chronic graft-versus-host disease. Browne PV; Weisdorf DJ; DeFor T; Miller WJ; Davies SM; Filipovich A; McGlave PB; Ramsay NK; Wagner J; Enright H Bone Marrow Transplant; 2000 Oct; 26(8):865-9. PubMed ID: 11081386 [TBL] [Abstract][Full Text] [Related]
6. The use of thalidomide in chronic refractory graft versus host disease. van de Poel MH; Pasman PC; Schouten HC Neth J Med; 2001 Aug; 59(2):45-9. PubMed ID: 11476911 [TBL] [Abstract][Full Text] [Related]
7. Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease. Chao NJ; Parker PM; Niland JC; Wong RM; Dagis A; Long GD; Nademanee AP; Negrin RS; Snyder DS; Hu WW; Gould KA; Tierney DK; Zwingenberger K; Forman SJ; Blume KG Biol Blood Marrow Transplant; 1996 May; 2(2):86-92. PubMed ID: 9118303 [TBL] [Abstract][Full Text] [Related]
9. Thalidomide in the treatment of graft-versus-host disease. Heney D; Bailey CC; Lewis IJ Biomed Pharmacother; 1990; 44(4):199-204. PubMed ID: 2204450 [TBL] [Abstract][Full Text] [Related]
10. Thalidomide for the therapy of graft-versus-host disease following allogeneic bone marrow transplantation. McCarthy DM; Kanfer EJ; Barrett AJ Biomed Pharmacother; 1989; 43(9):693-7. PubMed ID: 2696566 [TBL] [Abstract][Full Text] [Related]
11. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease. Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281 [TBL] [Abstract][Full Text] [Related]
12. Thalidomide back in good graces--seems to help GVHD patients. Oncology (Williston Park); 1988 Sep; 2(9):29. PubMed ID: 3275064 [No Abstract] [Full Text] [Related]
13. Severe cutaneous ulceration following treatment with thalidomide for GVHD. Schlossberg H; Klumpp T; Sabol P; Herman J; Mangan K Bone Marrow Transplant; 2001 Jan; 27(2):229-30. PubMed ID: 11281398 [TBL] [Abstract][Full Text] [Related]
14. Thalidomide for treatment of graft-versus-host disease. Vogelsang GB; Hess AD; Santos GW Bone Marrow Transplant; 1988 Sep; 3(5):393-8. PubMed ID: 3056547 [TBL] [Abstract][Full Text] [Related]
15. Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model. Vogelsang GB; Hess AD; Gordon G; Santos GW Transplantation; 1986 May; 41(5):644-7. PubMed ID: 2939610 [TBL] [Abstract][Full Text] [Related]